Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11926-015-0555-7 http://scihub22266oqcxt.onion/10.1007/s11926-015-0555-7 C4779139!4779139 !26943351     free     free     free Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\26943351 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Rheumatol+Rep 2016 ; 18 (2 ): 12 Nephropedia Template TP {{tp|p=26943351 |t=2016. Cellular Therapies in Systemic Sclerosis: Recent Progress |pdf=|usr=}}{{26943351 }} gab.com Text Cellular Therapies in Systemic Sclerosis: Recent Progress JO: Curr Rheumatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=26943351 #FOAvip Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with a high mortality and morbidity. While progress has been made in terms of identifying high-risk patients and implementing new treatment strategies, therapeutic options remain limited. In the past few decades, various cellular therapies have emerged, which have been studied in SSc and other conditions. Here, we provide a comprehensive review of currently available cellular therapies and critically assess their merit as disease-modifying treatment for SSc. Currently, hematopoietic stem cell transplantation is the only cellular therapy that has demonstrated clinical effects on the immune system, neoangiogenesis, and fibrosis. Robust mechanistic studies as well as clinical trials are essential to move the field forward. Twit Text FOAVip Cellular Therapies in Systemic Sclerosis: Recent Progress ????Curr Rheumatol Rep http://www.kidney.de/pget.php?&tw=1&pmid=26943351 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26943351 #FOAvip English Wikipedia <ref>{{Cite pmid|26943351 }}</ref> Cellular Therapies in Systemic Sclerosis: Recent Progress #MMPMID26943351 van Rhijn-Brouwer FC ; Gremmels H ; Fledderus JO ; Radstake TR ; Verhaar MC ; van Laar JM Curr Rheumatol Rep 2016[Feb]; 18 (2 ): 12 PMID26943351 show ga Systemic sclerosis (SSc) is a rare autoimmune connective tissue disease with a high mortality and morbidity. While progress has been made in terms of identifying high-risk patients and implementing new treatment strategies, therapeutic options remain limited. In the past few decades, various cellular therapies have emerged, which have been studied in SSc and other conditions. Here, we provide a comprehensive review of currently available cellular therapies and critically assess their merit as disease-modifying treatment for SSc. Currently, hematopoietic stem cell transplantation is the only cellular therapy that has demonstrated clinical effects on the immune system, neoangiogenesis, and fibrosis. Robust mechanistic studies as well as clinical trials are essential to move the field forward. |Clinical Trials as Topic/methods [MESH] |Dendritic Cells/transplantation [MESH] |Hematopoietic Stem Cell Transplantation/*methods/trends [MESH] |Humans [MESH] |Mesenchymal Stem Cell Transplantation/*methods/trends [MESH] |Scleroderma, Systemic/*therapy [MESH]Cellular Therapies in Systemic Sclerosis: Recent Progress (epmc).pdf DeepDyve Pubget Overpricing